Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7913595 | 0.77 | ADORA2A (0.79) | ADORA1ADORA2A | |
| SCHEMBL1536293 | 0.77 | ADORA2A (1.00) | ADORA1ADORA2A | |
| SCHEMBL20561885 | 0.76 | HTT (0.58) | ADORA1ADORA2A | |
| SCHEMBL7920486 | 0.76 | ADORA2A (0.76) | ADORA1ADORA2A | |
| SCHEMBL7925190 | 0.75 | ADORA2A (1.00) | ADORA1ADORA2A | |
| SCHEMBL7921850 | 0.75 | ADORA2A (0.75) | ADORA1ADORA2A | |
| SCHEMBL890081 | 0.74 | CCR1 (0.42) | ADORA1ADORA2A | |
| SCHEMBL7920165 | 0.74 | ADORA2A (0.77) | ADORA1ADORA2A | |
| SCHEMBL7920130 | 0.73 | ADORA2A (0.75) | ADORA1ADORA2A | |
| SCHEMBL7922302 | 0.73 | ADORA2A (0.71) | ADORA1ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8338605-B2 | Anti-viral compounds | ABBOTT LABORATORIES (US) | 2012-12-25 | — | — | US | disclosed |
| US-20100256139-A1 | Anti-Viral Compounds | ABBOTT LABORATORIES (US) | 2010-10-07 | — | — | US | disclosed |
| EP-1979349-B1 | ANTI-VIRAL COMPOUNDS | ABBOTT LAB (US) | 2010-07-28 | — | — | EP | disclosed |
| US-7763731-B2 | Anti-viral compounds | ABBOTT LABORATORIES (US) | 2010-07-27 | — | — | US | disclosed |
| US-20070232645-A1 | ANTI-VIRAL COMPOUNDS | ABBVIE INC. | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232645-A1 | ANTI-VIRAL COMPOUNDS | HAVCR2, MAVS, EIF2AK2 | ADORA1 3948/4885ADORA2A 3844/4885 |
| US-20100256139-A1 | Anti-Viral Compounds | HAVCR2, MAVS, EIF2AK2 | ADORA1 3948/4885ADORA2A 3844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.